Navigation Links
Researchers at Scripps to Study Possible New Treatment for Parkinson's Disease
Date:1/25/2013

SAN DIEGO, Jan. 25, 2013 /PRNewswire/ -- Scripps Clinic, in partnership with The Scripps Research Institute (TSRI), has begun the research phase of a proposed clinical trial using induced pluripotent stem cells to halt or reverse the effects of Parkinson's disease.

(Logo: http://photos.prnewswire.com/prnh/20121018/LA95241LOGO)

Under the leadership of Melissa Houser, MD, neurologist and medical director of Scripps Clinic's Parkinson's Disease and Movement Disorders Center, and co-investigator Jeanne F. Loring, PhD, professor and director of the Center for Regenerative Medicine at TSRI, skin cells taken from Parkinson's disease patients who meet select criteria are being cultivated in vitro and turned into pluripotent stem cells. These stem cells will be developed into dopamine-producing brain cells.

The plans, which will require Food and Drug Administration (FDA) approval, are to implant these cells back into the donor patients' brains; the goal is for the cells to integrate inside the brain and produce enough dopamine to alleviate the worst symptoms of Parkinson's disease. There are currently several clinical trials using pluripotent stem cells to replace cells lost to injury or neurodegenerative disease, as well as for the development of pharmaceuticals, but reimplantation of cells into the same patient for function restoration as a treatment for Parkinson's disease has never been attempted.  

"What sets our study apart from many others is that it's patient-specific," said Dr. Houser. "That means our patients who initially donated their skin cells will eventually receive their own cells again, with th
'/>"/>

SOURCE Scripps Health
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices
2. Van Andel Institute Researchers Find Potential Drug Target For Aggressive Form Of Lymphoma
3. Researchers Evaluate Computer-based Treatment for People with Schizophrenia
4. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
5. Researchers Developing New Multiple Sclerosis Drug That Can Be Taken Orally
6. Researchers Discover All-Natural Weapon In The War Against Ovarian Cancer
7. Latest Breakthroughs and Treatments in Spinal Cord Injury Medicine Bring Top Clinicians and Researchers Together in Las Vegas
8. Researchers Set Record for Detecting Smallest Virus, Opening New Possibilities for Early Disease Detection
9. Researchers and Patient Advocates Honored with PhRMA Award
10. Leading Researchers Outline Principles for Conduct of Comparative Effectiveness Research
11. As Prescription Painkiller Overdoses Mount, Researchers Outline Effective Approaches to Curb Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 This report analyzes the worldwide markets ... the following Segments: Standard Intraocular Lenses, and Premium Intraocular Lenses. ... Canada , Japan , ... Latin America , and Rest of World. Annual ... 2020. Also, a seven-year historic analysis is provided for these ...
(Date:5/28/2015)... Research and Markets ( ... the  "North America Ultrasound Devices Market - ...  report to their offering.       ... type of imaging. It uses high-frequency sound ... structures inside the body. Health care experts ...
(Date:5/28/2015)... , May 28, 2015 KaloBios Pharmaceuticals, Inc. ... Ronald A. Martell , to the position of ... of the KaloBios Board of Directors. In this new ... management team to refine and execute on the strategic ... company developing therapeutics for orphan oncology indications with high ...
Breaking Medicine Technology:World Intraocular Lenses Industry 2World Intraocular Lenses Industry 3World Intraocular Lenses Industry 4World Intraocular Lenses Industry 5World Intraocular Lenses Industry 6World Intraocular Lenses Industry 7World Intraocular Lenses Industry 8World Intraocular Lenses Industry 9World Intraocular Lenses Industry 10World Intraocular Lenses Industry 11World Intraocular Lenses Industry 12World Intraocular Lenses Industry 13World Intraocular Lenses Industry 14World Intraocular Lenses Industry 15World Intraocular Lenses Industry 16World Intraocular Lenses Industry 17World Intraocular Lenses Industry 18World Intraocular Lenses Industry 19World Intraocular Lenses Industry 20World Intraocular Lenses Industry 21World Intraocular Lenses Industry 22World Intraocular Lenses Industry 23World Intraocular Lenses Industry 24World Intraocular Lenses Industry 25World Intraocular Lenses Industry 26North America Ultrasound Devices Market Report 2014-2019 - Technology and Applications 2KaloBios Appoints Ronald A. Martell Executive Chairman 2KaloBios Appoints Ronald A. Martell Executive Chairman 3KaloBios Appoints Ronald A. Martell Executive Chairman 4KaloBios Appoints Ronald A. Martell Executive Chairman 5
... Inc. (Nasdaq: VRUS ) announced today the ... of Pharmasset,s PSI-7977, a nucleotide polymerase inhibitor, and BMS-790052, ... replication complex inhibitor, for the treatment of chronic hepatitis ... clinical collaboration agreement between Pharmasset and Bristol-Myers Squibb announced ...
... 26, 2011 Reportlinker.com announces that ... available in its catalogue: ... Steady Uptake of Oxycontin and High ... And Arthritis to Drive the Market ...
Cached Medicine Technology:All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated 2All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated 3Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 2Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 3Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 4Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 5Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 6Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 7Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 8Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 9Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 10Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 11Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 12Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 13Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 14Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 15Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 16Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 17Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 18
(Date:5/29/2015)... The annual aesthetic meeting, put on by the American ... from May 14-19th. This global event sets a gold ... world; dedicating itself exclusively to cosmetic medicine. Dr. Paul ... to attend this year’s meeting. , Among the classes ... given the honor of sitting at the presenter’s table during ...
(Date:5/29/2015)... 29, 2015 Vulvodynia is defined as ... significant physical, sexual, and psychological distress. Women’s ... Vulvodynia. The actual diagnosis is often made on the ... realize that this problem can be very troublesome to ... these symptoms, they need to schedule and appointment with ...
(Date:5/29/2015)... Health DataPalooza is a national conference that brings ... the most effective and innovative ways to use open ... by the Health Data Consortium, which is a collaboration ... develop the use of open healthcare data. Within ... in on how to actually put the ideas into ...
(Date:5/29/2015)... News: 2015-2016 Oil Market Forecast, Company: Carson ... , In July, 2014, the price of ... in US shale production and increased production from Saudi ... share from US shale producers, started producing close to ... out into the marketplace, they could push oil prices ...
(Date:5/29/2015)... Texas (PRWEB) May 29, 2015 Testosterone Centers ... the DFW area, is opening a new center in the ... the rest of the Mid Cities. Located on the south ... Road in Hurst, the new testosterone center will open in ... women who suffer from low testosterone. , Like TCT’s other ...
Breaking Medicine News(10 mins):Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:Breaking News: Carson Energy Releases 2015-2016 Oil Forecast 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3
... , , , ... TUSTIN, Calif. , July 14 Peregrine Pharmaceuticals, Inc. (Nasdaq: ... (FY) 2009 ended April 30, 2009. Total revenues for the fourth quarter ... in FY 2008. Total revenues for the 2009 fiscal year increased approximately ...
... , NEW YORK, July 14 Delcath Systems, Inc. (Nasdaq: ... for the second quarter ended June 30, 2009 on Monday, July 27, ... Eamonn Hobbs, the Company,s new President & CEO ... 2009 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss ...
... , DEERFIELD BEACH, Fla., July 14 A ... suggests drinking fat-free milk in the morning may be better than drinking ... However, the study only looks at feeling full, not weight loss ... are intolerant to proteins in milk, or lactose intolerant, which can cause ...
... ... under the knife? Advances in fractional laser technology have resulted in the Fractional Eyelift, a ... Bruce Katz of the Juva Skin & Laser Center pioneered the procedure. , ... (PRWEB) July 14, 2009 -- For many, ...
... , ... Institute and EmpowHer Publish a Series of Women,s Cardiovascular Health Content , ... Scottsdale, Arizona (PRWEB) July 14, ... and EmpowHer, ( www.empowher.com ), the home for women,s health online, today announced a ...
... , ... prescription discount card, Niche Prescriptions announces the grand opening of a new program. The ... one of the largest pharmacy networks in the United States and offers thousands of ... ...
Cached Medicine News:Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 2Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 3Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 4Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 5Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 6Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 7Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 8Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 9Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 10Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 11Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 12Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 13Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 14Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 15Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 16Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 17Health News:Delcath Systems to Host July 27th Conference Call to Update Investors on Recent Progress 2Health News:Milk: Does It Do A Body Good? 2Health News:Milk: Does It Do A Body Good? 3Health News:Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 2Health News:Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 3Health News:Free Women's Heart Health Information Now Available 2Health News:Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 2Health News:Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 3
SunGlide™ Stylette - Green Adult. Use in 7.0 to 10mm tubes. 25/box....
SunGlide™ Stylette - Blue Neonatal. Use in 2.0 to 3.5mm tubes. 25/box....
Disposable Aluminum Satin Finish E/T Stylette, Adult 16, 25/box....
Solid Copper Malleable with Adjustable Stop 14.75....
Medicine Products: